Iovance Biotherapeutics, Inc. (IOVA)
14.22
-0.02
(-0.11%)
USD |
NASDAQ |
Oct 02, 16:00
14.22
+0.01
(+0.07%)
After-Hours: 20:00
Iovance Biotherapeutics Price : 14.22 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 14.45 | 14.75 | 13.95 | 14.22 | 11.92M |
| Oct 01, 2026 | 14.76 | 15.03 | 14.19 | 14.23 | 15.97M |
| Sep 30, 2026 | 14.65 | 15.11 | 14.10 | 14.82 | 29.34M |
| Sep 29, 2026 | 12.79 | 15.30 | 12.78 | 14.45 | 78.17M |
| Sep 28, 2026 | 10.88 | 11.16 | 10.68 | 10.99 | 12.23M |
| Sep 25, 2026 | 10.90 | 11.13 | 10.69 | 11.00 | 12.63M |
| Sep 24, 2026 | 10.40 | 10.83 | 10.15 | 10.80 | 11.93M |
| Sep 23, 2026 | 10.69 | 10.84 | 10.12 | 10.19 | 15.92M |
| Sep 22, 2026 | 10.18 | 10.80 | 10.03 | 10.64 | 16.06M |
| Sep 21, 2026 | 10.43 | 10.64 | 10.03 | 10.19 | 13.13M |
| Sep 18, 2026 | 10.12 | 10.27 | 9.83 | 10.25 | 22.88M |
| Sep 17, 2026 | 10.25 | 10.98 | 9.985 | 10.02 | 24.20M |
| Sep 16, 2026 | 9.45 | 9.925 | 9.435 | 9.87 | 19.69M |
| Sep 15, 2026 | 9.21 | 9.38 | 8.98 | 9.36 | 11.09M |
| Sep 14, 2026 | 8.56 | 9.41 | 8.54 | 9.26 | 21.04M |
| Sep 11, 2026 | 8.25 | 8.695 | 8.075 | 8.60 | 12.39M |
| Sep 10, 2026 | 8.32 | 8.420 | 8.04 | 8.14 | 10.57M |
| Sep 09, 2026 | 8.655 | 8.73 | 8.32 | 8.43 | 11.94M |
| Sep 08, 2026 | 8.69 | 8.91 | 8.48 | 8.70 | 9.543M |
| Sep 04, 2026 | 8.74 | 8.90 | 8.635 | 8.79 | 8.080M |
| Sep 03, 2026 | 8.65 | 8.790 | 8.55 | 8.70 | 14.64M |
| Sep 02, 2026 | 8.31 | 8.69 | 8.295 | 8.62 | 12.39M |
| Sep 01, 2026 | 8.02 | 8.29 | 7.97 | 8.28 | 6.761M |
| Aug 31, 2026 | 7.945 | 8.17 | 7.66 | 8.17 | 12.13M |
| Aug 28, 2026 | 8.20 | 8.35 | 7.97 | 8.01 | 7.694M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AVITA Medical, Inc. | 12.72 |
| Amgen, Inc. | 403.04 |
| Halozyme Therapeutics, Inc. | 109.86 |
| Neurocrine Biosciences, Inc. | 143.18 |
| Editas Medicine, Inc. | 2.62 |
Price Related Metrics
| PS Ratio | 17.93 |
| Price to Book Value | 8.748 |
| Earnings Yield | -5.07% |
| Market Cap | 6.439B |